Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study (Q33359644)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study |
scientific article |
Statements
1 reference
Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study (English)
1 reference
Eckhard Thiel
1 reference
Miklos Pless
1 reference
Karim Belhadj
1 reference
Hans D Menssen
1 reference
Wolfgang Kern
1 reference
Bertrand Coiffier
1 reference
Jürgen Wolf
1 reference
Richard Herrmann
1 reference
Doug Bootle
1 reference
Ivo Sklenar
1 reference
Christian Müller
1 reference
Les Choi
1 reference
Carl Porter
1 reference
Renaud Capdeville
1 reference
1 February 2004
1 reference
1 reference
10
1 reference
1299-1305
1 reference
Identifiers
1 reference
1 reference